Influence of the COVID-19 Pandemic on Adherence to Orally Administered Antineoplastics
Background: Several factors can influence adherence to orally administered antineoplastics, including fear or anxiety resulting from situations such as the COVID-19 pandemic. The aim of this study was to analyse the influence of these patients’ experiences on adherence to orally administered antineo...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2022-04-01
|
| Series: | Journal of Clinical Medicine |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2077-0383/11/9/2436 |
| _version_ | 1797504210605965312 |
|---|---|
| author | Amparo Talens Elsa López-Pintor Marta Bejerano Mercedes Guilabert María Teresa Aznar Ignacio Aznar-Lou Blanca Lumbreras |
| author_facet | Amparo Talens Elsa López-Pintor Marta Bejerano Mercedes Guilabert María Teresa Aznar Ignacio Aznar-Lou Blanca Lumbreras |
| author_sort | Amparo Talens |
| collection | DOAJ |
| description | Background: Several factors can influence adherence to orally administered antineoplastics, including fear or anxiety resulting from situations such as the COVID-19 pandemic. The aim of this study was to analyse the influence of these patients’ experiences on adherence to orally administered antineoplastics. Methods: Cross-sectional study in four hospitals including >18 year old cancer patients receiving orally administered antineoplastics during the first half of 2021. Data were collected from medical records and through telephone interviews. Adherence was assessed through the prescription refill records and pill counts. Patients’ fear resulting from the pandemic was assessed by means of a structured questionnaire using a 5-point Likert-type scale. Results: Our sample compr BARCELONAised 268 patients (54% men) with a mean age of 64 years (SD 12). More than 15% had experienced afraid and 5% had experienced a dangerous situation when attending hospital, 17% felt they had received less care, and 30% preferred telepharmacy. Adherence measured by pill count was 69.3% and 95.5% according to prescription refill records. Patients who had experienced fear or anxiety when attending hospital were less adherent (aOR 0.47, 95% CI 0.23–0.96, <i>p</i> = 0.039). Conclusion: The fear experienced by some patients has affected adherence to treatment. |
| first_indexed | 2024-03-10T04:01:26Z |
| format | Article |
| id | doaj.art-648a5b4266034830af8c57bcf4d0602d |
| institution | Directory Open Access Journal |
| issn | 2077-0383 |
| language | English |
| last_indexed | 2024-03-10T04:01:26Z |
| publishDate | 2022-04-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Journal of Clinical Medicine |
| spelling | doaj.art-648a5b4266034830af8c57bcf4d0602d2023-11-23T08:32:18ZengMDPI AGJournal of Clinical Medicine2077-03832022-04-01119243610.3390/jcm11092436Influence of the COVID-19 Pandemic on Adherence to Orally Administered AntineoplasticsAmparo Talens0Elsa López-Pintor1Marta Bejerano2Mercedes Guilabert3María Teresa Aznar4Ignacio Aznar-Lou5Blanca Lumbreras6Servicio de Farmacia, Hospital General Universitario de Elda, 03600 Alicante, SpainDepartamento de Ingeniería, Área de Farmacia y Tecnología Farmacéutica, Universidad Miguel Hernández, 03550 Alicante, SpainServicio de Farmacia, Hospital General Universitario de Elda, 03600 Alicante, SpainDepartamento de Psicología de la Salud, Universidad Miguel Hernández, 03202 Alicante, SpainServicio de Farmacia, Hospital Universitario San Juan de Alicante, 03550 Alicante, SpainCenter for Biomedical Research in Epidemiology and Public Health Network (CIBERESP), 28029 Madrid, SpainCenter for Biomedical Research in Epidemiology and Public Health Network (CIBERESP), 28029 Madrid, SpainBackground: Several factors can influence adherence to orally administered antineoplastics, including fear or anxiety resulting from situations such as the COVID-19 pandemic. The aim of this study was to analyse the influence of these patients’ experiences on adherence to orally administered antineoplastics. Methods: Cross-sectional study in four hospitals including >18 year old cancer patients receiving orally administered antineoplastics during the first half of 2021. Data were collected from medical records and through telephone interviews. Adherence was assessed through the prescription refill records and pill counts. Patients’ fear resulting from the pandemic was assessed by means of a structured questionnaire using a 5-point Likert-type scale. Results: Our sample compr BARCELONAised 268 patients (54% men) with a mean age of 64 years (SD 12). More than 15% had experienced afraid and 5% had experienced a dangerous situation when attending hospital, 17% felt they had received less care, and 30% preferred telepharmacy. Adherence measured by pill count was 69.3% and 95.5% according to prescription refill records. Patients who had experienced fear or anxiety when attending hospital were less adherent (aOR 0.47, 95% CI 0.23–0.96, <i>p</i> = 0.039). Conclusion: The fear experienced by some patients has affected adherence to treatment.https://www.mdpi.com/2077-0383/11/9/2436COVIDadherenceorally administered antineoplasticshaemato-oncology patients |
| spellingShingle | Amparo Talens Elsa López-Pintor Marta Bejerano Mercedes Guilabert María Teresa Aznar Ignacio Aznar-Lou Blanca Lumbreras Influence of the COVID-19 Pandemic on Adherence to Orally Administered Antineoplastics Journal of Clinical Medicine COVID adherence orally administered antineoplastics haemato-oncology patients |
| title | Influence of the COVID-19 Pandemic on Adherence to Orally Administered Antineoplastics |
| title_full | Influence of the COVID-19 Pandemic on Adherence to Orally Administered Antineoplastics |
| title_fullStr | Influence of the COVID-19 Pandemic on Adherence to Orally Administered Antineoplastics |
| title_full_unstemmed | Influence of the COVID-19 Pandemic on Adherence to Orally Administered Antineoplastics |
| title_short | Influence of the COVID-19 Pandemic on Adherence to Orally Administered Antineoplastics |
| title_sort | influence of the covid 19 pandemic on adherence to orally administered antineoplastics |
| topic | COVID adherence orally administered antineoplastics haemato-oncology patients |
| url | https://www.mdpi.com/2077-0383/11/9/2436 |
| work_keys_str_mv | AT amparotalens influenceofthecovid19pandemiconadherencetoorallyadministeredantineoplastics AT elsalopezpintor influenceofthecovid19pandemiconadherencetoorallyadministeredantineoplastics AT martabejerano influenceofthecovid19pandemiconadherencetoorallyadministeredantineoplastics AT mercedesguilabert influenceofthecovid19pandemiconadherencetoorallyadministeredantineoplastics AT mariateresaaznar influenceofthecovid19pandemiconadherencetoorallyadministeredantineoplastics AT ignacioaznarlou influenceofthecovid19pandemiconadherencetoorallyadministeredantineoplastics AT blancalumbreras influenceofthecovid19pandemiconadherencetoorallyadministeredantineoplastics |